157 related articles for article (PubMed ID: 19779934)
21. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance and mechanism of TBX5 gene in colorectal cancer].
Dong MJ; Zhou Y; Duan M; Gao QM; Zhao JH
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):383-390. PubMed ID: 32482027
[No Abstract] [Full Text] [Related]
23. Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis.
Jo YK; Kim SC; Park IJ; Park SJ; Jin DH; Hong SW; Cho DH; Kim JC
PLoS One; 2012; 7(12):e52705. PubMed ID: 23285162
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer.
Yang M; Qu Y; Shi R; Wu X; Su C; Hu Z; Chang Q; Liu S; Pan G; Lei M; Xie F; Tu S; Tao W; Zhou H; Hu G; Zhang Z
Oncol Rep; 2016 Aug; 36(2):779-86. PubMed ID: 27349176
[TBL] [Abstract][Full Text] [Related]
27. UbcH10 is overexpressed in malignant breast carcinomas.
Berlingieri MT; Pallante P; Sboner A; Barbareschi M; Bianco M; Ferraro A; Mansueto G; Borbone E; Guerriero E; Troncone G; Fusco A
Eur J Cancer; 2007 Dec; 43(18):2729-35. PubMed ID: 17933517
[TBL] [Abstract][Full Text] [Related]
28. KIAA0101 and UbcH10 interact to regulate non-small cell lung cancer cell proliferation by disrupting the function of the spindle assembly checkpoint.
Lei H; Wang K; Jiang T; Lu J; Dong X; Wang F; Li Q; Zhao L
BMC Cancer; 2020 Oct; 20(1):957. PubMed ID: 33008389
[TBL] [Abstract][Full Text] [Related]
29. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
[TBL] [Abstract][Full Text] [Related]
30. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
[TBL] [Abstract][Full Text] [Related]
31. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of the peripheral benzodiazepine receptor during human colorectal carcinogenesis and tumor spread.
Maaser K; Grabowski P; Oezdem Y; Krahn A; Heine B; Stein H; Buhr H; Zeitz M; Scherübl H
Clin Cancer Res; 2005 Mar; 11(5):1751-6. PubMed ID: 15755996
[TBL] [Abstract][Full Text] [Related]
33. UBE2Q1 expression in human colorectal tumors and cell lines.
Shafiee SM; Seghatoleslam A; Nikseresht M; Hosseini SV; Alizadeh-Naeeni M; Safaei A; Owji AA
Mol Biol Rep; 2013 Dec; 40(12):7045-51. PubMed ID: 24197692
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
35. UbcH10 overexpression is less pronounced in older colorectal cancer patients.
Pellino G; Pallante P; Malapelle U; Ferraro A; Bellevicine C; Milone M; Troncone G; Fusco A; Selvaggi F;
Int J Colorectal Dis; 2016 Jul; 31(7):1367-8. PubMed ID: 26744065
[No Abstract] [Full Text] [Related]
36. Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer.
Fujita T; Ikeda H; Taira N; Hatoh S; Naito M; Doihara H
BMC Cancer; 2009 Mar; 9():87. PubMed ID: 19302711
[TBL] [Abstract][Full Text] [Related]
37. A study of UbcH10 expression and its association with recurrence of meningiomas.
Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC
J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464
[TBL] [Abstract][Full Text] [Related]
38. Characterization of cathepsin X in colorectal cancer development and progression.
Jechorek D; Votapek J; Meyer F; Kandulski A; Roessner A; Franke S
Pathol Res Pract; 2014 Dec; 210(12):822-9. PubMed ID: 25442015
[TBL] [Abstract][Full Text] [Related]
39. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
[TBL] [Abstract][Full Text] [Related]
40. High UBCH10 protein expression as a marker of poor prognosis in esophageal squamous cell carcinoma.
Matsumoto A; Ishibashi Y; Urashima M; Omura N; Nakada K; Nishikawa K; Shida A; Takada K; Kashiwagi H; Yanaga K
Anticancer Res; 2014 Feb; 34(2):955-61. PubMed ID: 24511039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]